Zurich, Switzerland

Klaus Dietmeier

USPTO Granted Patents = 2 



Average Co-Inventor Count = 7.1

ph-index = 2

Forward Citations = 22(Granted Patents)


Location History:

  • Zurich, CH (2010)
  • Zürich, CH (2013)

Company Filing History:


Years Active: 2010-2013

Loading Chart...
Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Klaus Dietmeier: Innovator in Immunology

Introduction

Klaus Dietmeier is a prominent inventor based in Zurich, Switzerland. He has made significant contributions to the fields of immunology and allergy treatment through his innovative patents. With a total of two patents to his name, Dietmeier is recognized for his work in developing novel therapeutic compositions.

Latest Patents

Dietmeier's latest patents include "Immunostimulatory nucleic acid packaged particles for the treatment of hypersensitivity." This application focuses on compositions and methods aimed at treating hypersensitivity, particularly atopic eczema, asthma, and IgE-mediated allergies, such as pollen and house dust allergies. His second patent, "CAT allergen conjugates and uses thereof," involves compositions that include virus-like particles or virus particles combined with feline antigens. This invention is particularly relevant for producing vaccines to treat and prevent allergies to cat dander and other related allergens.

Career Highlights

Klaus Dietmeier is associated with Cytos Biotechnology AG, where he continues to advance research in immunology. His work has the potential to significantly impact public health by providing new solutions for allergy sufferers.

Collaborations

Dietmeier has collaborated with notable colleagues, including Martin F. Bachmann and Wolfgang Andreas Renner. These partnerships have contributed to the development of his innovative ideas and patents.

Conclusion

Klaus Dietmeier's contributions to immunology and allergy treatment through his patents highlight his role as a key innovator in the field. His work continues to pave the way for advancements in therapeutic solutions for hypersensitivity and allergies.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…